权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Core--Clinical

核心--临床

基本信息

批准号：
7631320
负责人：
JOSEPH Wayne FAY
金额：
$ 13.52万
依托单位：
BAYLOR RESEARCH INSTITUTE
依托单位国家：
美国
项目类别：
财政年份：
2000
资助国家：
美国
起止时间：
2000-09-30 至
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/7631320
关键词：
Academic Medical Centers Accreditation Adherence Adverse event Amendment Area Autologous Blood Blood Component Removal Bone Marrow Transplantation Books CD34 gene Case Report Form Cell Therapy Cells Clinical Clinical Data Clinical Protocols Clinical Research Clinical Research Protocols Clinical Trials Clinical Trials Data Monitoring Committees Clinical Trials Design Code Collaborations Collection Color Confidentiality Consent Forms Data Data Collection Dendritic Cell Vaccine Dendritic Cells Documentation Effectiveness Enrollment Ensure Foundations Guanosine Monophosphate Guidelines Health Insurance Portability and Accountability Act Hematopoietic stem cells Human Human Subject Research Immunology Immunotherapy Individual Informed Consent Institutes Laboratories Laboratory Research Laboratory Study Metastatic Melanoma Mission Monitor Monitoring Clinical Trials Mononuclear National Cancer Institute Nursing Staff Operative Surgical Procedures Outcomes Research Patient Participation Patients Performance Personal Computers Pharmaceutical Preparations Policies Principal Investigator Procedures Protocols documentation Records Reporting Research Research Ethics Committees Research Institute Research Personnel Safety Secure Standards of Weights and Measures Time United States Update Vaccine Design Vaccines Writing healthy volunteer human subject improved melanoma monocyte novel strategies patient safety progenitor programs research study response volunteer

项目摘要

The clinical core has the responsibility of implementation and close monitoring of the clinical trials investigating the effectiveness of dendritic cell (DC) immunotherapy for metastatic melanoma as outlined in the specific aims of investigators at the Baylor Institute for Immunology Research. The functions of the Clinical Core are divided into four general areas: (1) Performance of clinical trials involving patients with metastatic melanoma with the highest level of good clinical practice; (2) Implementation of clinical research after approval by the Institutional Review Board (IRB) of the Baylor University Medical Center (BUMC), the National Cancer Institute (NCI) and the United States Federal Drug Administration (FDA); (3) Write, implement and update as necessary a clinical trial monitoring policy as mandated by the Baylor Research Institute (BRI) in Dallas and the FDA in collaboration with our outside clinical protocol monitors to promote accurate collection of clinical and laboratory research data, prompt and comprehensive reporting of adverse events as a result of patient participation in clinical research to the IRB,NCI and FDA and to ensure patient safety; (4) Operate and oversee the apheresis center at BUMC to ensure patient safety and proper collection of autologous mononuclear cells for DC vaccine design; (5) Maintain high quality records of patient participation and document regulatory activities of the clinical research in collaboration with the DC Core in a manner acceptable to the IRB,NCI and FDA. The core will be responsible for the integrity of the clinical outcomes of the research. We have established a Data Safety and Monitoring Board (DSMB) and a Melanoma Trials Overview Committee (MTOC) as oversight entities.

临床核心有责任实施和密切监测临床试验调查树突状细胞(DC)免疫治疗转移性黑色素瘤的有效性贝勒免疫研究所的研究人员。临床核心的功能分为四个方面一般领域：(1)涉及转移性黑色素瘤患者的临床试验表现良好的临床实践；(2)经机构审查委员会批准后实施临床研究贝勒大学医学中心(BUMC)、国家癌症研究所(NCI)和美国联邦药物管理局管理局(FDA)；(3)根据以下要求编写、实施和更新必要的临床试验监测政策达拉斯的贝勒研究所(BRI)和FDA与我们的外部临床方案合作监测促进准确收集临床和实验室研究数据，及时全面报告不良反应将患者参与临床研究的事件提交给IRB、NCI和FDA，并确保患者安全；(4) 运营并监督北京医科大学的分离中心，以确保患者的安全和自体血液的正确收集用于DC疫苗设计的单个核细胞；(5)维护患者参与和文档的高质量记录以IRB、NCI可接受的方式与DC核心合作的临床研究的规范活动和FDA。核心将负责研究临床结果的完整性。我们已经建立了一个数据安全和监测委员会(DSMB)和黑色素瘤试验概览委员会(MTOC)作为监督实体。